BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31648322)

  • 1. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis.
    Ailawadhi S; Parikh K; Abouzaid S; Zhou Z; Tang W; Clancy Z; Cheung C; Zhou ZY; Xie J
    Blood Adv; 2019 Oct; 3(20):2986-2994. PubMed ID: 31648322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
    Ailawadhi S; Frank RD; Sharma M; Menghani R; Temkit M; Paulus S; Khera N; Hashmi S; Advani P; Swaika A; Paulus A; Aslam N; Sher T; Roy V; Colon-Otero G; Chanan-Khan A
    Cancer; 2018 Apr; 124(8):1710-1721. PubMed ID: 29360160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.
    Ailawadhi S; Frank RD; Advani P; Swaika A; Temkit M; Menghani R; Sharma M; Meghji Z; Paulus S; Khera N; Hashmi SK; Paulus A; Kakar TS; Hodge DO; Colibaseanu DT; Vizzini MR; Roy V; Colon-Otero G; Chanan-Khan AA
    Cancer Med; 2017 Dec; 6(12):2876-2885. PubMed ID: 29105343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
    Schriber JR; Hari PN; Ahn KW; Fei M; Costa LJ; Kharfan-Dabaja MA; Angel-Diaz M; Gale RP; Ganguly S; Girnius SK; Hashmi S; Pawarode A; Vesole DH; Wiernik PH; Wirk BM; Marks DI; Nishihori T; Olsson RF; Usmani SZ; Mark TM; Nieto YL; D'Souza A
    Cancer; 2017 Aug; 123(16):3141-3149. PubMed ID: 28472539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database.
    Shah GL; Winn AN; Lin PJ; Klein A; Sprague KA; Smith HP; Buchsbaum R; Cohen JT; Miller KB; Comenzo R; Parsons SK
    Biol Blood Marrow Transplant; 2015 Oct; 21(10):1823-9. PubMed ID: 26033281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States.
    Warren JL; Harlan LC; Stevens J; Little RF; Abel GA
    J Clin Oncol; 2013 Jun; 31(16):1984-9. PubMed ID: 23569317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
    Badar T; Hari P; Dávila O; Fraser R; Wirk B; Dhakal B; Freytes CO; Rodriguez Valdes C; Lee C; Vesole DH; Malek E; Hildebrandt GC; Landau H; Murthy HS; Lazarus HM; Berdeja JG; Meehan KR; Solh M; Diaz MA; Kharfan-Dabaja MA; Callander NS; Farhadfar N; Bashir Q; Kamble RT; Vij R; Munker R; Kyle RA; Chhabra S; Hashmi S; Ganguly S; Jagannath S; Nishihori T; Nieto Y; Kumar S; Shah N; D'Souza A
    Cancer; 2021 Jan; 127(1):82-92. PubMed ID: 32966625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of race on outcomes of autologous transplantation in patients with multiple myeloma.
    Verma PS; Howard RS; Weiss BM
    Am J Hematol; 2008 May; 83(5):355-8. PubMed ID: 18186525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.
    Ailawadhi S; Aldoss IT; Yang D; Razavi P; Cozen W; Sher T; Chanan-Khan A
    Br J Haematol; 2012 Jul; 158(1):91-8. PubMed ID: 22533740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
    Ailawadhi S; Azzouqa AG; Hodge D; Cochuyt J; Jani P; Ahmed S; Sher T; Roy V; Ailawadhi M; Alegria VR; Manochakian R; Vishnu P; Grover A; Abdulazeez MF; Paulus A; Chanan-Khan A
    Clin Lymphoma Myeloma Leuk; 2019 Oct; 19(10):619-623. PubMed ID: 31377212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
    Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
    Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival.
    Nurgalieva ZZ; Franzini L; Morgan R; Vernon SW; Liu CC; Du XL
    Med Oncol; 2013 Dec; 30(4):691. PubMed ID: 23975632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/ethnic disparities in the adjuvant chemotherapy of locally advanced colon cancer patients.
    Zhong X; Guo Z; Gao P; Song Y; Sun J; Chen X; Sun Y; Wang Z
    J Surg Res; 2018 Aug; 228():27-34. PubMed ID: 29907221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in Utilization of Autologous Stem Cell Transplantation as Consolidative Therapy for Multiple Myeloma: A Single Institution Retrospective Review.
    Lupak O; Xiaoxia H; Xie P; Thanikachalam K; Jabbour-Aida H; Farhan S; Emole J
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e680-e685. PubMed ID: 34148850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato-Oncology (HOLA) Observational Study, 2008-2016.
    de Moraes Hungria VT; Martínez-Baños DM; Peñafiel CR; Miguel CE; Vela-Ojeda J; Remaggi G; Duarte FB; Cao C; Cugliari MS; Santos T; Machnicki G; Fernandez M; Grings M; Ammann EM; Lin JH; Chen YW; Wong YN; Barreyro P
    Br J Haematol; 2020 Feb; 188(3):383-393. PubMed ID: 31392724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma.
    Fiala MA; Finney JD; Liu J; Stockerl-Goldstein KE; Tomasson MH; Vij R; Wildes TM
    Leuk Lymphoma; 2015; 56(9):2643-9. PubMed ID: 25651424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in treatment use for multiple myeloma.
    Fiala MA; Wildes TM
    Cancer; 2017 May; 123(9):1590-1596. PubMed ID: 28085188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report.
    Alkhouli M; Holmes DR; Carroll JD; Li Z; Inohara T; Kosinski AS; Szerlip M; Thourani VH; Mack MJ; Vemulapalli S
    JACC Cardiovasc Interv; 2019 May; 12(10):936-948. PubMed ID: 31122351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001-2010: a retrospective, population based analysis.
    Tangen JM; Tjønnfjord GE; Gulbrandsen N; Gedde-Dahl T; Stormorken E; Anderson K; Vo CD; Schjesvold FH;
    BMC Cancer; 2018 Aug; 18(1):801. PubMed ID: 30089450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.